Evaluating the feasibility of prolonged-release buprenorphine formulations as an alternative to daily opioid agonist therapy regardless of prior treatment adherence: a pilot study

BACKGROUND: Effective opioid agonist therapy (OAT) depends on good patient adherence. However, the daily, supervised administration of standard OAT represents a significant burden to patients and often drives poor adherence. Prolonged-release buprenorphine (PRB) formulations may mitigate some of thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Hard, Bernadette, DeSilva, Mohan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10318660/
https://www.ncbi.nlm.nih.gov/pubmed/37403145
http://dx.doi.org/10.1186/s40814-023-01348-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10318660/
https://www.ncbi.nlm.nih.gov/pubmed/37403145
http://dx.doi.org/10.1186/s40814-023-01348-5

Ejemplares similares